Fred Alger Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $4.23 Million - $16 Million	-179,046 Reduced 98.38%	2,949 $112,000
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $19,093 - $23,234	-249 Reduced 0.14%	181,995 $16.6 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $1.12 Million - $1.61 Million	-24,019 Reduced 11.64%	182,244 $12 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $3.11 Million - $4.39 Million	71,961 Added 53.58%	206,263 $10.7 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $98,337 - $153,043	-2,197 Reduced 1.61%	134,302 $9.17 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $2.37 Million - $4.01 Million	67,716 Added 98.45%	136,499 $6.17 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $2.44 Million - $3.72 Million	68,783 New	68,783 $3.5 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $604,288 - $850,003	-14,811 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $456,030 - $847,189	14,811 New	14,811 $847,000
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $124,000 - $192,450	-5,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $179,100 - $443,300	-10,000 Reduced 66.67%	5,000 $134,000
Q4 2019 Feb 14, 2020	SELL	$22.1 - $30.8 $353,600 - $492,800	-16,000 Reduced 51.61%	15,000 $459,000
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $674,520 - $901,040	28,000 Added 933.33%	31,000 $747,000
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $54,000 - $76,020	3,000 New	3,000 $76,000

310

113M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.